RhumbLine Advisers’s Athira Pharma ATHA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-1,532
| Closed | -$4.06K | – | 4204 |
|
|
2024
Q2 | $4.06K | Hold |
1,532
| – | – | ﹤0.01% | 4115 |
|
|
2024
Q1 | $4.2K | Hold |
1,532
| – | – | ﹤0.01% | 4002 |
|
|
2023
Q4 | $3.72K | Hold |
1,532
| – | – | ﹤0.01% | 4028 |
|
|
2023
Q3 | $3.09K | Sell |
1,532
-2,838
| -65% | -$5.73K | ﹤0.01% | 4057 |
|
|
2023
Q2 | $12.9K | Sell |
4,370
-47,698
| -92% | -$141K | ﹤0.01% | 3889 |
|
|
2023
Q1 | $130K | Sell |
52,068
-186
| -0.4% | -$464 | ﹤0.01% | 2824 |
|
|
2022
Q4 | $166K | Buy |
52,254
+1,799
| +4% | +$5.72K | ﹤0.01% | 2831 |
|
|
2022
Q3 | $150K | Buy |
50,455
+3,142
| +7% | +$9.34K | ﹤0.01% | 2950 |
|
|
2022
Q2 | $144K | Buy |
47,313
+6,942
| +17% | +$21.1K | ﹤0.01% | 2997 |
|
|
2022
Q1 | $545K | Sell |
40,371
-864
| -2% | -$11.7K | ﹤0.01% | 2390 |
|
|
2021
Q4 | $537K | Sell |
41,235
-525
| -1% | -$6.84K | ﹤0.01% | 2478 |
|
|
2021
Q3 | $392K | Buy |
41,760
+1,500
| +4% | +$14.1K | ﹤0.01% | 2657 |
|
|
2021
Q2 | $412K | Buy |
40,260
+28,494
| +242% | +$292K | ﹤0.01% | 2650 |
|
|
2021
Q1 | $216K | Buy |
11,766
+1,168
| +11% | +$21.4K | ﹤0.01% | 2812 |
|
|
2020
Q4 | $363K | Buy |
+10,598
| New | +$363K | ﹤0.01% | 2580 |
|